Articles from Transplant News (July 27, 2002)

Title	Author	Type	Words
Aastrom Biosciences receives orphan product designation from FDA for bone marrow stem cell product.		Brief Article	138
Advanced Tissue Sciences begins trials for periodontal treatment, heart tissue patch.		Brief Article	255
After making major changes following death of live donor, Mount Sinai liver transplant reopens.		Brief Article	294
Antinori says birth of first cloned baby could occur around Christmas.		Brief Article	369
Australia to allow xenotransplant research providing scientists follow stringent guidelines.		Brief Article	216
Cleveland Clinic expected heart transplant survival rate tops in US.		Brief Article	159
CryoLife hit with 7 lawsuits over death of Minnesota man attributed to tainted tissue.		Brief Article	342
Ixion Biotechnology receives NIH funds to study if liver stem cells can provide diabetes treatment.		Brief Article	129
Japanese company that received stolen genes denies criminal wrongdoing.		Brief Article	179
Lifebank Cryogenics seeking to become first publicly traded stem cell bank in Canada.		Brief Article	175
NIDDK launches new kidney disease education web site for health providers.		Brief Article	188
NKF receives grant from MultiPlan to reprint transplant patient guide.		Brief Article	112
Organ donor myths pervasive among Canadians, contribute to low donation rates, poll finds.		Brief Article	384
Persistent sexual problems, other ailments impact QOL of renal transplant recipients.		Brief Article	340
Renal allograft loss often caused by recurrent glomerulonephritis.		Brief Article	90
Small bowel transplant no longer a treatment of last resort.		Brief Article	309
Transplant may provide long-lasting benefits to some type 1 diabetics-study.		Brief Article	319
US donor pool stabilizes but less than half become donors, minority consent continues to lag, study finds.	Grygotis, Michele	Brief Article	420
With no federal legislation in sight, Washington, Iowa, Ohio pass laws to increase organ/tissue donation.		Brief Article	395